SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2498)6/23/2010 1:34:55 PM
From: Jibacoa1 Recommendation  Read Replies (1) | Respond to of 3722
 
SUPG i bouncing up from support at the $2.20 level, apparently after some positive comments at the Motley Fool.<g>

The stock is up 4.74% on volume >2x its ADV

But it has a good amount of resistance at $2.25 <g>

bigcharts.marketwatch.com

SUPG has 3Qs of better revenues and earnings were also a little better in the last 2Qs.
But it is still expected to report losses in 2010 & 2011
However, those losses have been revised down and SUPG has NLTD and small +CF
The insiders reportedly hold >20% of the stock and it has a fair institutional following.
bigcharts.marketwatch.com

The ACTAY is $6.75
That would be a 300% gain from present levels.<g>
Although the stock has plenty of room to run, I will keep a target at just $2.50 pending further developments.<g>

bigcharts.marketwatch.com

Bernard